Free Trial
OTCMKTS:CVSI

CV Sciences (CVSI) Stock Price, News & Analysis

CV Sciences logo
$0.03 0.00 (0.00%)
As of 06/5/2026 12:46 PM Eastern

About CV Sciences Stock (OTCMKTS:CVSI)

Advanced

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.03
$0.04
52-Week Range
$0.02
$0.10
Volume
16,026 shs
Average Volume
364,388 shs
Market Capitalization
$6.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CV Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

CVSI MarketRank™: 

CV Sciences scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for CV Sciences.

  • Price to Book Value per Share Ratio

    CV Sciences has a P/B Ratio of 2.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.01% of the float of CV Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    CV Sciences has a short interest ratio ("days to cover") of 0.01, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CV Sciences has recently increased by 8.94%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    CV Sciences does not currently pay a dividend.

  • Dividend Growth

    CV Sciences does not have a long track record of dividend growth.

  • News Sentiment

    CV Sciences has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for CV Sciences this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, CV Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    6.70% of the stock of CV Sciences is held by insiders.

  • Percentage Held by Institutions

    CV Sciences has minimal institutional ownership at this time.

  • Read more about CV Sciences' insider trading history.
Receive CVSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CV Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CVSI Stock News Headlines

Important SpaceX PREDICTION
The biggest IPO in stock market history could go live as soon as June 12th — but trading legend Jon Najarian says investors are about to miss the real opportunity. A little-known FCC filing Elon quietly submitted earlier this year has caught Morgan Stanley's attention — and they estimate it could be worth $40 trillion. That's larger than Tesla, xAI, Starlink, X, Neuralink, and SpaceX combined.tc pixel
See More Headlines

CVSI Stock Analysis - Frequently Asked Questions

CV Sciences' stock was trading at $0.0614 on January 1st, 2026. Since then, CVSI shares have decreased by 52.1% and is now trading at $0.0294.

CV Sciences, Inc. (OTCMKTS:CVSI) posted its quarterly earnings results on Thursday, August, 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.03). The business had revenue of $5.13 million for the quarter, compared to analysts' expectations of $5.12 million. CV Sciences had a negative net margin of 11.15% and a negative trailing twelve-month return on equity of 94.61%.

Shares of CVSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CV Sciences investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Charlotte's Web (CWBHF), Cronos Group (CRON), Kushco (KSHB), NVIDIA (NVDA) and Organigram Global (OGI).

Company Calendar

Last Earnings
8/12/2021
Today
6/08/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CVSI
Previous Symbol
NASDAQ:CVSI
CIK
1510964
Employees
70
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$960 thousand
Net Margins
-11.15%
Pretax Margin
-11.14%
Return on Equity
-94.61%
Return on Assets
-20.85%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.96
Quick Ratio
0.21

Sales & Book Value

Annual Sales
$13.79 million
Price / Sales
0.43
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.01 per share
Price / Book
2.94

Miscellaneous

Outstanding Shares
203,978,000
Free Float
190,311,000
Market Cap
$6.00 million
Optionable
Not Optionable
Beta
0.42

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (OTCMKTS:CVSI) was last updated on 6/8/2026 by MarketBeat.com Staff.
From Our Partners